Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis

Pathobiology

Volumn 68, Issue 4-5, 2000, Pages 165-172

  Stoehr, Robert ^a   Hartmann, Arndt ^a   Hiendlmeyer, Elke ^a   Mürle, Kristin ^a   Wieland, Wolfgang ^b   Knuechel, Ruth ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b CARITAS KRANKENHAUS ST JOSEF   (Germany)

Author keywords

Clonality; Fluorescence in situ hybridization; Loss of heterozygosity; Microdissection; Urothelial lesions

Indexed keywords

MICROSATELLITE DNA;

BLADDER CANCER; CHROMOSOME MICRODISSECTION; CONFERENCE PAPER; CONTROLLED STUDY; CYSTECTOMY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; GENOME; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TREATMENT OUTCOME; TUMOR GROWTH; UROTHELIUM; X CHROMOSOME INACTIVATION;

CARCINOMA IN SITU; CELL SEPARATION; CLONE CELLS; CYSTECTOMY; DISSECTION; HUMANS; LASERS; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0034461465     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055919     Document Type: Conference Paper

References (30)

1. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B: Clonal origin bladder cancer. N Engl J Med 1992;326: 737-740.
2. Harris AL, Neal DE: Bladder cancer - Field versus clonal origin. N Engl J Med 1992;326: 759-761.
3. Bender CM, Jones PA: Molecular genetics in carcinoma of the bladder; in Petrovich ZBLBL (ed): Carcinoma of the Bladder: Innovations in Management. Heidelberg, Springer, 1999, pp 37-51.
4. Kriegmair M, Baumgartner R, Knuechel R, Stepp H, Hostaedter F, Hofstetter A: Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996;155:105-109.
5. Jichlinski P, Forrer M, Mizeret J, Glanzmann T, Braichotte D, Wagnieres G, Zimmer G, Guillou L, Schmidlin F, Graber P, van den Bergh H, Leisinger HJ: Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: Preliminary results. Lasers Surg Med 1997;20:402-408.
6. Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R: Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999;154: 721-727.
7. Hartmann A, Rosner U, Schlake G, Dietmaier W, Zaak D, Hofstaedter F, Knuechel R: Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosomes 9 and p53 deletion analysis. Lab Invest 2000;80:709-718.
8. Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Roy JY, Luthra R, Logothetis C, von Eschenbach AC, Grossman HB, Benedict WF, Batsakis JG: Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia. Implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene 1999;18: 1185-1196.
9. Dietmaier W, Hartmann A, Wallinger S, Heinmoller E, Kerner T, Endl E, Jauch KW, Hofstaedter F, Ruschoff J: Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol 1999;154: 83-95.
10. Sobin LH, Wittekind C: TNM Classification of Malignant Tumours. New York, Wiley-Liss, 1997.
11. Murphy WM, Beckwith JB, Farrow GE: Atlas of tumor pathology; in Rosai J, Sobin LH (eds): Tumors of the Kidney, Bladder, and Related Urinary Structures. Washington, Armed Forces Institute of Pathology, 1994.
12. Mostofi FK, Davis CJJ, Sesterhenn IA: Histological typing of urinary bladder tumours; in World Health Organization - International Histological Classification. Berlin, Springer, 1999.
13. Wild P, Knuechel R, Dietmaier W, Hofstaedter F, Hartmann A: Laser microdissection and microsatellite analyses of breast cancer reveal a high degree of tumor heterogeneity. Pathobiology 2001;68:180-190.
14. Schlegel J, Bocker T, Zirngibl H, Hofstaedter F, Ruschoff J: Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based screening technique. Virchows Arch 1995;426:223-227.
15. Futreal PA, Barrett JC, Wiseman RW: An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res 1991;19:6977.
16. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W: Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 1995;11:210-212.
17. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci USA 1993;90:10914-10921.
18. Bohm M, Kirch H, Otto T, Rubben H, Wieland I: Deletion analysis at the DEL-27, APC and MTS1 loci in bladder cancer: LOH at the DEL-27 locus on 5p13-12 is a prognostic marker of tumor progression. Int J Cancer 1997;74:291-295.
19. Garcia SB, Novelli M, Wright NA: The clonal origin and clonal evolution of epithelial tumours. Int J Exp Pathol 2000;81:89-116.
20. Tsai YC, Simoneau AR, Spruck CH, Nichols PW, Steven K, Buckley JD, Jones PA: Mosaicism in human epithelium: Macroscopic monoclonal patches cover the urothelium. J Urol 1995;153:1697-1700.
21. Baud E, Catilina P, Boiteux JP, Bignon YJ: Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome-9 deletion. Int J Cancer 1998;77:821-824.
22. Koss L: Tumors of the urinary bladder; in Atlas of Tumor Pathology. Washington, Armed Forces Institute of Pathology, 1975.
23. Wagner U, Sauter G, Moch H, Novotna H, Epper R, Mihatsch MJ, Waldman FM: Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder. Hum Pathol 1995;26:970-978.
24. Muto S, Horie S, Takahashi S, Tomita K, Kitamura T: Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer. Cancer Res 2000; 60:4021-4025.
25. Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS, Cote R: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994;54:784-788.
26. van Tilborg AA, Groenfeld LE, van der Kwast TH, Zwarthoff EC: Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines. Br J Cancer 1999;80:489-494.
27. Simoneau M, Aboulkassim TO, LaRue H, Rousseau F, Fradet Y: Four tumor suppressor loci on chromosome 9q in bladder cancer: Evidence for two novel candidate regions at 9q22.3 and 9q31. Oncogene 1999;18:157-163.
28. Hsu HC, Chiou TJ, Chen JY, Lee CS, Lee PH, Peng SY: Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology 1991;13:923-928.
29. Vogelstein B, Fearon ER, Hamilton SR, Preisinger AC, Willard HF, Michelson AM, Riggs AD, Orkin SH: Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 1987;47:4806-4813.
30. Schneider A, Borgnat S, Lang H, Regine O, Lindner V, Kassem M, Saussine C, Oudet P, Jacqmin D, Gaub MP: Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. Cancer Res 2000;60:4617-4622.